335 related articles for article (PubMed ID: 11013246)
1. Tau filament formation in transgenic mice expressing P301L tau.
Götz J; Chen F; Barmettler R; Nitsch RM
J Biol Chem; 2001 Jan; 276(1):529-34. PubMed ID: 11013246
[TBL] [Abstract][Full Text] [Related]
2. Oligodendroglial tau filament formation in transgenic mice expressing G272V tau.
Götz J; Tolnay M; Barmettler R; Chen F; Probst A; Nitsch RM
Eur J Neurosci; 2001 Jun; 13(11):2131-40. PubMed ID: 11422454
[TBL] [Abstract][Full Text] [Related]
3. Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau.
Lin WL; Lewis J; Yen SH; Hutton M; Dickson DW
J Neurocytol; 2003 Nov; 32(9):1091-105. PubMed ID: 15044841
[TBL] [Abstract][Full Text] [Related]
4. Tau protein is cross-linked by transglutaminase in P301L tau transgenic mice.
Halverson RA; Lewis J; Frausto S; Hutton M; Muma NA
J Neurosci; 2005 Feb; 25(5):1226-33. PubMed ID: 15689560
[TBL] [Abstract][Full Text] [Related]
5. Hyperphosphorylated tau aggregates in the cortex and hippocampus of transgenic mice with mutant human FTDP-17 Tau and lacking the PARK2 gene.
Guerrero R; Navarro P; Gallego E; Garcia-Cabrero AM; Avila J; Sanchez MP
Acta Neuropathol; 2009 Feb; 117(2):159-68. PubMed ID: 19057915
[TBL] [Abstract][Full Text] [Related]
6. Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice.
Terwel D; Lasrado R; Snauwaert J; Vandeweert E; Van Haesendonck C; Borghgraef P; Van Leuven F
J Biol Chem; 2005 Feb; 280(5):3963-73. PubMed ID: 15509565
[TBL] [Abstract][Full Text] [Related]
7. Divergent phosphorylation pattern of tau in P301L tau transgenic mice.
Deters N; Ittner LM; Götz J
Eur J Neurosci; 2008 Jul; 28(1):137-47. PubMed ID: 18662339
[TBL] [Abstract][Full Text] [Related]
8. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein.
Lewis J; McGowan E; Rockwood J; Melrose H; Nacharaju P; Van Slegtenhorst M; Gwinn-Hardy K; Paul Murphy M; Baker M; Yu X; Duff K; Hardy J; Corral A; Lin WL; Yen SH; Dickson DW; Davies P; Hutton M
Nat Genet; 2000 Aug; 25(4):402-5. PubMed ID: 10932182
[TBL] [Abstract][Full Text] [Related]
9. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L).
Ramsden M; Kotilinek L; Forster C; Paulson J; McGowan E; SantaCruz K; Guimaraes A; Yue M; Lewis J; Carlson G; Hutton M; Ashe KH
J Neurosci; 2005 Nov; 25(46):10637-47. PubMed ID: 16291936
[TBL] [Abstract][Full Text] [Related]
10. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils.
Götz J; Chen F; van Dorpe J; Nitsch RM
Science; 2001 Aug; 293(5534):1491-5. PubMed ID: 11520988
[TBL] [Abstract][Full Text] [Related]
11. Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration.
Higuchi M; Ishihara T; Zhang B; Hong M; Andreadis A; Trojanowski J; Lee VM
Neuron; 2002 Aug; 35(3):433-46. PubMed ID: 12165467
[TBL] [Abstract][Full Text] [Related]
12. Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein.
Allen B; Ingram E; Takao M; Smith MJ; Jakes R; Virdee K; Yoshida H; Holzer M; Craxton M; Emson PC; Atzori C; Migheli A; Crowther RA; Ghetti B; Spillantini MG; Goedert M
J Neurosci; 2002 Nov; 22(21):9340-51. PubMed ID: 12417659
[TBL] [Abstract][Full Text] [Related]
13. Filamentous tau in oligodendrocytes and astrocytes of transgenic mice expressing the human tau isoform with the P301L mutation.
Lin WL; Lewis J; Yen SH; Hutton M; Dickson DW
Am J Pathol; 2003 Jan; 162(1):213-8. PubMed ID: 12507904
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1.
Boutajangout A; Authelet M; Blanchard V; Touchet N; Tremp G; Pradier L; Brion JP
Neurobiol Dis; 2004 Feb; 15(1):47-60. PubMed ID: 14751770
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis in oligodendrocytes is associated with axonal degeneration in P301L tau mice.
Zehr C; Lewis J; McGowan E; Crook J; Lin WL; Godwin K; Knight J; Dickson DW; Hutton M
Neurobiol Dis; 2004 Apr; 15(3):553-62. PubMed ID: 15056463
[TBL] [Abstract][Full Text] [Related]
16. Rapid neurofibrillary tangle formation after localized gene transfer of mutated tau.
Klein RL; Lin WL; Dickson DW; Lewis J; Hutton M; Duff K; Meyer EM; King MA
Am J Pathol; 2004 Jan; 164(1):347-53. PubMed ID: 14695347
[TBL] [Abstract][Full Text] [Related]
17. Aggregation of detergent-insoluble tau is involved in neuronal loss but not in synaptic loss.
Kimura T; Fukuda T; Sahara N; Yamashita S; Murayama M; Mizoroki T; Yoshiike Y; Lee B; Sotiropoulos I; Maeda S; Takashima A
J Biol Chem; 2010 Dec; 285(49):38692-9. PubMed ID: 20921222
[TBL] [Abstract][Full Text] [Related]
18. Transgenic mouse model of tau pathology in astrocytes leading to nervous system degeneration.
Forman MS; Lal D; Zhang B; Dabir DV; Swanson E; Lee VM; Trojanowski JQ
J Neurosci; 2005 Apr; 25(14):3539-50. PubMed ID: 15814784
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the cholinergic pathology in the P301L tau transgenic pR5 model of tauopathy.
Köhler C; Bista P; Götz J; Schröder H
Brain Res; 2010 Aug; 1347():111-24. PubMed ID: 20513372
[TBL] [Abstract][Full Text] [Related]
20. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform.
Ishihara T; Hong M; Zhang B; Nakagawa Y; Lee MK; Trojanowski JQ; Lee VM
Neuron; 1999 Nov; 24(3):751-62. PubMed ID: 10595524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]